Study results show radiotherapy in fewer but larger doses is safe for early breast cancer

According to findings of the FAST trial, five larger radiotherapy doses after surgery, once-a-week sessions for five weeks instead of daily radiotherapy over the same time, totalling 25 doses, cause similarly low rates of side-effects in women with early-stage breast cancer in the long run. Fewer treatment sessions would particularly benefit patients at low risk

Continue Reading

Vertex and NHS reach agreement for “Landmark” CF therapy deal

Vertex has achieved an agreement with NHS England to reimburse its triple combination therapy Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor), should the medicine win European approval. The new expanded agreement includes reimbursed access to Vertex’ currently licensed medicines – Kalydeco (ivacaftor), Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor), as well as the triple combination therapy if

Continue Reading

NHS and Microsoft sign significant deal for digital tools

NHSX, NHS Digital and Microsoft have signed a ‘landmark’ deal which will save the NHS ‘hundreds of millions of pounds’ and enable all eligible organisations in England to access Microsoft 365 digital tools. According to NHS Digital, the agreement ‘guarantees significant cost savings for both individual NHS organisations and the NHS as a whole’, and

Continue Reading

NHS launches new online support for diabetes management

NHS England has launched new online services allowing those with diabetes to better manage their condition remotely during the coronavirus pandemic. A range of online videos and training will be available for children and adults, which will include advice on treatment and care and adopting healthy behaviours on diet and exercise, complementing video consultations with

Continue Reading

Analysis by CRUK reveals 2 million are waiting for cancer care due to Coronavirus

According to Cancer Research UK, approximately 2.4 million people in the UK are currently waiting for cancer screening, tests or cancer treatment. The charity says COVID-19 has caused ‘enormous disruption’ to cancer services throughout the UK, with delays to cancer treatment, screening and diagnosis, and ‘huge decreases’ in urgent referrals to hospital of patients with

Continue Reading